{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:03:45Z","timestamp":1794852225510,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2022M712307"],"award-info":[{"award-number":["2022M712307"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["821RC1068"],"award-info":[{"award-number":["821RC1068"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2022ZB573"],"award-info":[{"award-number":["2022ZB573"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172294"],"award-info":[{"award-number":["82172294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["YX13400214"],"award-info":[{"award-number":["YX13400214"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In mice, liver fibrosis is the most serious pathologic change during\n                      <jats:italic>Schistosoma japonicum<\/jats:italic>\n                      (\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      ) infection. Schistosomiasis is mainly characterized by schistosome egg-induced granulomatous fibrosis. Hepatic stellate cells (HSCs) are mainly responsible for the net accumulation of collagens and fibrosis formation in the liver. Activated HSCs regulated by transforming growth factor-\u03b21 (TGF-\u03b21)\/Smad signaling have emerged as the critical regulatory pathway in hepatitis virus or carbon tetrachloride-induced liver fibrosis. However, the detailed mechanism of HSC activation in schistosome-induced liver fibrosis is poorly understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Schistosoma japonicum<\/jats:italic>\n                      -induced murine models and a control group were generated by abdominal infection with 15 (\u00b1\u20091) cercariae. The purity of cultured primary HSCs was evaluated by immunocytochemistry. The histopathological changes in the livers of infected mice were estimated by hematoxylin\u2013eosin and Masson staining. Dynamic expression of pro-fibrotic molecules and microRNAs was detected by real-time quantitative PCR (RT-qPCR). Mainly members involved in the TGF-\u03b21\/Smad signaling pathway were examined via RT-qPCR and Western blot.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The egg-induced granulomatous inflammation formed at 4\u00a0weeks post-infection (wpi) and developed progressively. Alpha-smooth muscle actin (\u03b1-SMA), collagen I, collagen III, TGF-\u03b21, Smad2, Smad3, and Smad4 showed a significant increase in mitochondrial RNA (mRNA) and protein expression compared with the control group at 7 and 9 weeks post-infection (wpi), while an opposite effect on Smad7 was  observed. In addition, the mRNA expression of microRNA-21 (miRNA-21) was significantly increased at 7 wpi, and the mRNA expression of miRNA-454 was decreased starting from 4 wpi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our present findings revealed that HSCs regulated by the TGF-\u03b21\/Smad signaling pathway play an important role in liver fibrosis in\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      -infected mice, which may provide proof of concept for liver fibrosis in schistosomiasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-022-05584-1","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:13:41Z","timestamp":1670328821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-\u03b21\/Smad signaling in schistosomiasis in mice"],"prefix":"10.1186","volume":"15","author":[{"given":"Ping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingzheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"5584_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4:13.","journal-title":"Nat Rev Dis Primers"},{"key":"5584_CR2","unstructured":"WHO. Schistosomiasis. In: Schistosomiasis; 2021. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 5 May 2021."},{"key":"5584_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/17441692.2020.1869799","volume":"17","author":"B Manjang","year":"2022","unstructured":"Manjang B, Ochola EA, Elliott SJ. The use of non-pharmaceutical interventions for the prevention and control of schistosomiasis in sub-Saharan Africa: a systematic review. Glob Public Health. 2022;17:469\u201382.","journal-title":"Glob Public Health"},{"key":"5584_CR4","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"5584_CR5","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.3390\/jcm10235521","volume":"10","author":"C Carbonell","year":"2021","unstructured":"Carbonell C, Rodr\u00edguez-Alonso B, L\u00f3pez-Bern\u00fas A, Almeida H, Galindo-P\u00e9rez I, Velasco-Tirado V, et al. Clinical spectrum of schistosomiasis: an Update. J Clin Med. 2021;10:5521.","journal-title":"J Clin Med"},{"key":"5584_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3389\/fimmu.2020.00593","volume":"11","author":"P Huang","year":"2020","unstructured":"Huang P, Zhou M, Cheng S, Hu Y, Gao M, Ma Y, et al. Myricetin possesses anthelmintic activity and attenuates hepatic fibrosis via modulating TGF\u03b21 and Akt signaling and shifting Th1\/Th2 balance in Schistosoma japonicum-infected mice. Front Immunol. 2020;11:593.","journal-title":"Front Immunol"},{"key":"5584_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.31743","volume":"74","author":"SB Rosenthal","year":"2021","unstructured":"Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, et al. Heterogeneity of HSCs in a mouse model of NASH. Hepatology. 2021;74:667\u201385.","journal-title":"Hepatology"},{"key":"5584_CR8","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/hep.32083","volume":"74","author":"S Win","year":"2021","unstructured":"Win S, Min RWM, Zhang J, Kanel G, Wanken B, Chen Y, et al. Hepatic mitochondrial SAB deletion or knockdown alleviates diet-induced metabolic syndrome, steatohepatitis, and hepatic fibrosis. Hepatology. 2021;74:3127\u201345.","journal-title":"Hepatology"},{"key":"5584_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cells8101249","volume":"8","author":"M Khatun","year":"2019","unstructured":"Khatun M, Ray RB. Mechanisms underlying hepatitis c virus-associated hepatic fibrosis. Cells. 2019;8:1249.","journal-title":"Cells"},{"key":"5584_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","volume":"17","author":"A Beringer","year":"2018","unstructured":"Beringer A, Miossec P. IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases. Autoimmun Rev. 2018;17:1176\u201385.","journal-title":"Autoimmun Rev"},{"key":"5584_CR11","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217:e20190103.","journal-title":"J Exp Med"},{"key":"5584_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, et al. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol. 2020;73:896\u2013905.","journal-title":"J Hepatol"},{"key":"5584_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"5584_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, Zhang L. TGF-\u03b2\/SMAD Pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157\u201367.","journal-title":"J Histochem Cytochem"},{"key":"5584_CR15","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1002\/ctm2.410","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, et al. Rebalancing TGF-\u03b2\/Smad7 signaling via compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin Transl Med. 2021;11:e410.","journal-title":"Clin Transl Med"},{"key":"5584_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35:3\u201311.","journal-title":"Semin Liver Dis"},{"key":"5584_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70:784\u201395.","journal-title":"Gut"},{"key":"5584_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/hep.27671","volume":"61","author":"X He","year":"2015","unstructured":"He X, Xie J, Zhang D, Su Q, Sai X, Bai R, et al. Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways. Hepatology. 2015;61:2008\u201317.","journal-title":"Hepatology"},{"key":"5584_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1756-3305-7-148","volume":"7","author":"D Zhu","year":"2014","unstructured":"Zhu D, He X, Duan Y, Chen J, Wang J, Sun X, et al. Expression of microRNA-454 in TGF-\u03b21-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors. 2014;7:148.","journal-title":"Parasit Vectors"},{"key":"5584_CR20","doi-asserted-by":"publisher","first-page":"696069","DOI":"10.3389\/fimmu.2021.696069","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Wang P, Wang YS, Zhang YN, Li C, Yang ZY, et al. MiR-130a-3p alleviates liver fibrosis by suppressing HSCs activation and skewing macrophage to Ly6Clo phenotype. Front Immunol. 2021;12:696069.","journal-title":"Front Immunol"},{"key":"5584_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.molcel.2014.02.013","volume":"53","author":"JW Nam","year":"2014","unstructured":"Nam JW, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014;53:1031\u201343.","journal-title":"Mol Cell"},{"key":"5584_CR22","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"5584_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.28948","volume":"65","author":"T Kisseleva","year":"2017","unstructured":"Kisseleva T. The origin of fibrogenic myofibroblasts in fibrotic liver. Hepatology. 2017;65:1039\u201343.","journal-title":"Hepatology"},{"key":"5584_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck 3rd","year":"2018","unstructured":"Gieseck RL 3rd, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18:62\u201376.","journal-title":"Nat Rev Immunol"},{"key":"5584_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5584_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"5584_CR27","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","volume":"178","author":"JA Fallowfield","year":"2007","unstructured":"Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. 2007;178:5288\u201395.","journal-title":"J Immunol"},{"key":"5584_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep.30252","volume":"69","author":"ME Inzaugarat","year":"2019","unstructured":"Inzaugarat ME, Johnson CD, Holtmann TM, McGeough MD, Trautwein C, Papouchado BG, et al. NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice. Hepatology. 2019;69:845\u201359.","journal-title":"Hepatology"},{"key":"5584_CR29","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/hep.31987","volume":"74","author":"W Yang","year":"2021","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K, et al. Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice. Hepatology. 2021;74:2774\u201390.","journal-title":"Hepatology"},{"key":"5584_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74:156\u201367.","journal-title":"J Hepatol"},{"key":"5584_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13071-019-3539-z","volume":"12","author":"L Chen","year":"2019","unstructured":"Chen L, Zhou Q, Liu E, Zhang J, Duan L, Zhu D, et al. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7\/Smad1\/5\/8 pathway. Parasit Vectors. 2019;12:279.","journal-title":"Parasit Vectors"},{"key":"5584_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.pt.2018.02.005","volume":"34","author":"JP Carson","year":"2018","unstructured":"Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-induced fibrotic disease: the role of hepatic stellate cells. Trends Parasitol. 2018;34:524\u201340.","journal-title":"Trends Parasitol"},{"key":"5584_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13071-021-04790-7","volume":"14","author":"L Chen","year":"2021","unstructured":"Chen L, Ji X, Wang M, Liao X, Liang C, Tang J, et al. Involvement of TLR4 signaling regulated-COX2\/PGE2 axis in liver fibrosis induced by Schistosoma japonicum infection. Parasit Vectors. 2021;14:279.","journal-title":"Parasit Vectors"},{"key":"5584_CR34","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123:1902\u201310.","journal-title":"J Clin Invest"},{"key":"5584_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/liv.14390","volume":"40","author":"MA Karsdal","year":"2020","unstructured":"Karsdal MA, Daniels SJ, Holm Nielsen S, Bager C, Rasmussen DGK, Loomba R, et al. Collagen biology and non-invasive biomarkers of liver fibrosis. Liver Int. 2020;40:736\u201350.","journal-title":"Liver Int"},{"key":"5584_CR36","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/DDDT.S186726","volume":"12","author":"M Mu","year":"2018","unstructured":"Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, et al. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-\u03b2\/Smad signaling pathway. Drug Des Devel Ther. 2018;12:4107\u201315.","journal-title":"Drug Des Devel Ther"},{"key":"5584_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/ijms17030280","volume":"17","author":"CN Hayes","year":"2016","unstructured":"Hayes CN, Chayama K. MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int J Mol Sci. 2016;17:280.","journal-title":"Int J Mol Sci"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05584-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05584-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05584-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:18:18Z","timestamp":1670329098000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05584-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5584"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05584-1","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were performed following the Administration of Affairs Concerning Experimental Animals (1988.11.1), and all efforts were made to minimize animal suffering. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Soochow University for the use of laboratory animals (Permit Number: 201604A136).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}